Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$71,073,704
+$18,373,486 QoQ
Shares Held
282,442
+16.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#306
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TODD ASSET MANAGEMENT LLC holds $250,852,520 across 11 Drug Manufacturers - General names. ABBV ranks #1 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
282,442 | $71,073,704 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
421,984 | $53,313,458 | |
| 3 | NVS |
Novartis AG
|
317,429 | $49,747,472 | |
| 4 | AMGN |
Amgen Inc
|
108,134 | $39,157,483 | |
| 5 | SNY |
Sanofi
|
674,143 | $28,758,939 | |
| 6 | NVO |
Novo Nordisk A S
|
134,460 | $6,446,012 | |
| 7 | JNJ |
Johnson & Johnson
|
3,288 | $835,053 | |
| 8 | PFE |
Pfizer Inc
|
27,801 | $669,448 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,073,704 | 282,442 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $52,700,218 | 242,311 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $51,188,842 | 224,031 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $51,938,357 | 224,317 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $42,411,571 | 228,486 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $48,367,901 | 230,851 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $40,760,115 | 229,376 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $44,787,674 | 226,796 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $38,929,551 | 226,968 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,738,048 | 229,204 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $38,099,374 | 245,850 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $43,118,139 | 289,267 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $39,027,239 | 289,670 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $52,136,939 | 327,144 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $50,001,325 | 309,395 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $41,621,607 | 310,123 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $47,960,522 | 313,140 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $55,539,696 | 342,605 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $47,044,594 | 347,449 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $39,289,166 | 364,227 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $41,253,048 | 366,238 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $35,695,501 | 329,842 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $35,445,862 | 330,806 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $39,147,562 | 446,941 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $29,863,116 | 304,167 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $25,223,613 | 331,062 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||